339 related articles for article (PubMed ID: 24646734)
1. CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.
Carrega P; Bonaccorsi I; Di Carlo E; Morandi B; Paul P; Rizzello V; Cipollone G; Navarra G; Mingari MC; Moretta L; Ferlazzo G
J Immunol; 2014 Apr; 192(8):3805-15. PubMed ID: 24646734
[TBL] [Abstract][Full Text] [Related]
2. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
[TBL] [Abstract][Full Text] [Related]
3. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
4. Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade.
Mehling M; Burgener AV; Brinkmann V; Bantug GR; Dimeloe S; Hoenger G; Kappos L; Hess C
Scand J Immunol; 2015 Nov; 82(5):460-6. PubMed ID: 26285786
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
[TBL] [Abstract][Full Text] [Related]
6. Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.
Messaoudene M; Fregni G; Fourmentraux-Neves E; Chanal J; Maubec E; Mazouz-Dorval S; Couturaud B; Girod A; Sastre-Garau X; Albert S; Guédon C; Deschamps L; Mitilian D; Cremer I; Jacquelot N; Rusakiewicz S; Zitvogel L; Avril MF; Caignard A
Cancer Res; 2014 Jan; 74(1):81-92. PubMed ID: 24225017
[TBL] [Abstract][Full Text] [Related]
7. Role of chemokines in the biology of natural killer cells.
Maghazachi AA
Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
[TBL] [Abstract][Full Text] [Related]
8. Heat shock suppresses human NK cell cytotoxicity via regulation of perforin.
Harada H; Murakami T; Tea SS; Takeuchi A; Koga T; Okada S; Suico MA; Shuto T; Kai H
Int J Hyperthermia; 2007 Dec; 23(8):657-65. PubMed ID: 18097852
[TBL] [Abstract][Full Text] [Related]
9. [Human peripheral blood CD56+ natural killer cell subsets and their phenotypic and biological properties].
Wu CY; Liu J; Yang BY; Roedere M
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):169-72. PubMed ID: 16875598
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis.
Plantone D; Marti A; Frisullo G; Iorio R; Damato V; Nociti V; Patanella AK; Bianco A; Mirabella M; Batocchi AP
J Neuroimmunol; 2013 Dec; 265(1-2):124-7. PubMed ID: 24157130
[TBL] [Abstract][Full Text] [Related]
11. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
12. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma.
Schleypen JS; Baur N; Kammerer R; Nelson PJ; Rohrmann K; Gröne EF; Hohenfellner M; Haferkamp A; Pohla H; Schendel DJ; Falk CS; Noessner E
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):718-25. PubMed ID: 16467081
[TBL] [Abstract][Full Text] [Related]
14. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer.
Rezaeifard S; Talei A; Shariat M; Erfani N
Mol Immunol; 2021 Aug; 136():161-167. PubMed ID: 34171565
[TBL] [Abstract][Full Text] [Related]
15. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.
Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS
J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331
[TBL] [Abstract][Full Text] [Related]
16. A novel epitope of N-CAM defines precursors of human adherent NK cells.
Li S; Xu J; Makarenkova VP; Tjandrawan T; Vakkila J; Reichert T; Gooding W; Lagenaur CF; Achim CL; Chambers WH; Herberman RB; Whiteside TL; Vujanovic NL
J Leukoc Biol; 2004 Dec; 76(6):1187-99. PubMed ID: 15356097
[TBL] [Abstract][Full Text] [Related]
17. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.
Reeves RK; Gillis J; Wong FE; Yu Y; Connole M; Johnson RP
Blood; 2010 Jun; 115(22):4439-46. PubMed ID: 20339088
[TBL] [Abstract][Full Text] [Related]
18. Human natural killer cell subsets and acute exercise: a brief review.
Timmons BW; Cieslak T
Exerc Immunol Rev; 2008; 14():8-23. PubMed ID: 19203081
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic functions and susceptibility to apoptosis of human CD56(bright) NK cells differentiated in vitro from CD34⁺ hematopoietic progenitors.
Zamai L; Del Zotto G; Buccella F; Galeotti L; Canonico B; Luchetti F; Papa S
Cytometry A; 2012 Apr; 81(4):294-302. PubMed ID: 22319021
[TBL] [Abstract][Full Text] [Related]
20. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.
Bonorino P; Ramzan M; Camous X; Dufeu-Duchesne T; Thélu MA; Sturm N; Dariz A; Guillermet C; Pernollet M; Zarski JP; Marche PN; Leroy V; Jouvin-Marche E
J Hepatol; 2009 Sep; 51(3):458-67. PubMed ID: 19596474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
